ReadyCell currently has a broad range of innovative ready-to-use kits on the market. Our R&D activities are focused on developing innovative in vitro tools for ADME-Monolayer assays, as well as major efflux and uptake transporters and Toxicity-Metabolism.

Applying excellent science and personalized service, ReadyCell can provide customer ready-to-use in vitro kits that increase efficiency and reduce costs on early drug discovery phases of new pharmaceutical developments.


Nowadays, ReadyCell R&D department is working in the development and launching of the following products: